Leap Therapeutics Inc (LPTX)
2.65
-0.09
(-3.28%)
USD |
NASDAQ |
May 17, 16:00
2.65
0.00 (0.00%)
After-Hours: 20:00
Leap Therapeutics Enterprise Value: 45.71M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 45.71M |
| May 16, 2024 | 49.92M |
| May 15, 2024 | 52.22M |
| May 14, 2024 | 50.31M |
| May 13, 2024 | 53.37M |
| May 10, 2024 | 51.45M |
| May 09, 2024 | 56.43M |
| May 08, 2024 | 59.49M |
| May 07, 2024 | 62.55M |
| May 06, 2024 | 68.29M |
| May 03, 2024 | 67.14M |
| May 02, 2024 | 66.38M |
| May 01, 2024 | 70.20M |
| April 30, 2024 | 63.70M |
| April 29, 2024 | 62.55M |
| April 26, 2024 | 69.44M |
| April 25, 2024 | 66.38M |
| April 24, 2024 | 70.97M |
| April 23, 2024 | 67.53M |
| April 22, 2024 | 67.91M |
| April 19, 2024 | 52.22M |
| April 18, 2024 | 58.34M |
| April 17, 2024 | 59.87M |
| April 16, 2024 | 59.11M |
| April 15, 2024 | 59.87M |
| Date | Value |
|---|---|
| April 12, 2024 | 28.03M |
| April 11, 2024 | 24.83M |
| April 10, 2024 | 22.91M |
| April 09, 2024 | 32.39M |
| April 08, 2024 | 11.14M |
| April 05, 2024 | 10.11M |
| April 04, 2024 | 9.344M |
| April 03, 2024 | 9.856M |
| April 02, 2024 | 12.42M |
| April 01, 2024 | 15.49M |
| March 28, 2024 | -2.547M |
| March 27, 2024 | 0.5253M |
| March 26, 2024 | -7.155M |
| March 25, 2024 | -9.203M |
| March 22, 2024 | -6.131M |
| March 21, 2024 | -5.363M |
| March 20, 2024 | -5.363M |
| March 19, 2024 | -14.32M |
| March 18, 2024 | -15.86M |
| March 15, 2024 | -14.07M |
| March 14, 2024 | -14.32M |
| March 13, 2024 | -12.02M |
| March 12, 2024 | -6.643M |
| March 11, 2024 | -7.155M |
| March 08, 2024 | -6.730M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-66.21M
Minimum
Apr 11 2023
275.84M
Maximum
Sep 24 2021
31.68M
Average
31.51M
Median
Nov 18 2020
Enterprise Value Benchmarks
| Cutera Inc | 358.38M |
| OrthoPediatrics Corp | 725.56M |
| AIM ImmunoTech Inc | 7.729M |
| Protalix BioTherapeutics Inc | 55.51M |
| Armata Pharmaceuticals Inc | 187.82M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -13.82M |
| Total Expenses (Quarterly) | 14.58M |
| EPS Diluted (Quarterly) | -0.51 |
| Earnings Yield | -80.99% |
| Normalized Earnings Yield | -180.60 |